Post-marketing surveillance in South Korea is required to monitor drug safety and efficacy after approval. Manufacturers must conduct periodic safety updates, report adverse drug reactions, and submit safety data to the Ministry of Food and Drug Safety (MFDS). This process ensures ongoing assessment of potential risks and necessary regulatory actions for approved drugs.
